| Completed |
: Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Ca
: 2005-06-13
: Drug: topotecan hydrochloride
|
| Completed |
: Vaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Peritoneal Cavity Can
: 2005-06-02
: - Biological: fowlpox-NY-ESO-1 vaccine
|
| Completed |
: OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206
: - Ovarian Neoplasms
- Fallopian Tube Neoplasms
- Peritoneal Neop
: 2005-05-27
: Drug: Neoadjuvant chemotherapy (Paclitaxel and Carboplatin)
|
| Active, not recruiting |
: Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer
: - Fallopian Tube Clear Cell Adenocarcinoma
- Fallopian Tube Endometrioid Adenocarcinoma
: 2005-04-18
: - Other: Clinical Observation Un
|
| Completed |
: Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response
: - Ovarian Cancer
- Fallopian Tube Neoplasms
- Peritoneal Neoplas
: 2005-02-10
: Biological: ACA 125
|
| Completed |
: Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
: - Ovarian Cancer
- Peritoneal Cavity Cancer
: 2005-01-07
: Biological: therapeutic autologous lymphocytes
|
| Completed |
: Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Ca
: 2004-12-08
: Drug: carboplatin
|
| Completed |
: CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Ca
: 2004-11-09
: Drug: CP-547,632
|
| Completed |
: Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer
: - Primary Peritoneal Cavity Cancer
- Recurrent Ovarian Epithelial Cancer
-
- Drug: gemcitabine hydrochloride
|
| Completed |
: Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Ca
: 2004-09-07
: - Drug: cisplatin IV 40 mg/m2 on
|
